Collectively, CBM treatments may improve pain scores, but study limitations such as small sample sizes and study durations, high placebo response rates, and trial unblinding because of the psychoactive effects of cannabinoids all hinder data interpretation and the extrapolation to chronic pain conditions.
Opioids and Cannabis: An Uncertain Combination?
Clinical commentary on research requires accessible peer-reviewed abstracts for evidence-based analysis. This PubMed link appears invalid, preventing responsible clinical review of the study methodology and findings.
Week in Weed – April 25, 2026 – StratCann
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Industry NewsRegulatory UpdatesClinical PracticeEvidence Review Why This Matters Without access to the specific content...
Medicinal Cannabis Matters: Friday Roundup – 24 April 2026 – Medicann
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Clinical PracticeEvidence ReviewMedical CannabisRegulatory Updates Why This Matters Without access to the specific content...
#ICYMI Our Zoe Mowery explored a pioneering Virginia Tech study on how cannabis use …
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Research QualityMedia LiteracyEvidence ReviewClinical Practice Why This MattersWithout access to the specific study...
#ICYMI Our Zoe Mowery explored a pioneering Virginia Tech study on how cannabis use …
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Research QualityMedia LiteracyEvidence ReviewClinical Practice Why This MattersWithout access to the specific study...
Lobsters in the News April 3, 2026 – Lobster Institute – The University of Maine
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Research QualityEvidence ReviewClinical Practice Why This MattersWithout access to the actual content of this...
Week in Weed – April 4, 2026 – StratCann
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Clinical PracticeEvidence ReviewCannabis NewsProfessional Standards Why This MattersWithout access to the specific clinical developments...
Cannabis-based interventions might help a little with neuropathic pain – Study Summary
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Neuropathic PainPain ManagementCannabinoidsChronic PainEvidence Review Why This MattersNeuropathic pain affects millions of patients...
Major review finds “very little evidence” for cannabis treating anxiety, PTSD, or psychotic …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Mental HealthPtsdEvidence ReviewAnxietyClinical Research Why This MattersThis review challenges widespread clinical assumptions about cannabis...